Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevent CSA-AKI Trial
NCT06620523Phase 2Recruiting
- Sponsor
- George Washington University
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Coenzyme Q10 mucoadhesive tablets, glutathione in acute kidney injury (AKI), sponsored by George Washington University. Started Jul 2024; status: recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tabletsglutathione
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06620523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06620523.